Zhounan Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhounan Zhu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Bin Zhang
Department of Hyperbaric Oxygen Treatment, First Affiliated Hospital of Naval Military Medical University, Shanghai, China
1 shared publication- Chen Li
The First Affiliated Hospital of Soochow University
1 shared publication - Chenggang Zheng
Department of Hyperbaric Oxygen Treatment, First Affiliated Hospital of Naval Military Medical University, Shanghai, China
1 shared publication Hongjie Yi
Department of Hyperbaric Oxygen Treatment, First Affiliated Hospital of Naval Military Medical University, Shanghai, China
1 shared publicationJiahao Ye
The First Affiliated Hospital of Soochow University
1 shared publication- Qinghe Tang
Department of Hepatobiliary and Pancreatic Surgery, Shanghai East Hospital, Tongji University School of Medicine
1 shared publication
Latest Publications
- Open Access
- 1 February 2026
- Published by SAGE Publications in Digital Health
- Vol. 12
Insights into the quality and guideline consistency of dry eye disease treatment videos on Chinese short-video platforms
Purpose: This study aimed to evaluate the quality of dry eye disease (DED) treatment–related short videos on popular Chinese platforms. Methods: To better evaluate the quality of short videos related to DED treatment, the Dry-eye-related Short Videos Standardization Score (DSVSS), a preliminary disease-specific checklist, was developed tailored to DED clinical guidelines. On May 17, 2025, 305 videos (150 from Douyin, 155 from Bilibili) were retrieved using the keyword “dry eye treatment”, and their quality and guideline consistency were evaluated with the Global Quality Score (GQS) and the DSVSS checklist. Basic data, including duration, likes, comments, collections, and shares were recorded. Statistical analysis was performed using the Mann–Whitney U test, Kruskal–Wallis H test, and Spearman’s rank correlation to assess group differences and correlations. Results: Videos from Douyin were generally shorter but achieved higher user engagement, while videos from Bilibili were longer with lower interaction (both P P =0.041), and median DSVSS was 3 for both ( P =0.116). Videos performed poorly in DSVSS checklist in definition and classification [0.05 (IQR 0.03–0.07)], emphasizing chronicity [0.07 (0.05–0.10)], and individualized treatment [0.08 (0.03–0.10)], but performed well in avoiding exaggeration [0.84 (0.63–0.91)], absence of advertising [0.78 (0.66–0.88)], and in providing warnings for special populations [0.91 (0.87–0.96)] (P<0.001). Conclusions: This study effectively identified critical deficiencies of current short-videos on DED treatment, underscoring the necessity for more professional, guideline-based content and stricter platform supervision to improve the quality of online health information.
- 1 February 2026
- Published by SAGE Publications in Digital Health
- Vol. 12
Open AccessInsights into the quality and guideline consistency of dry eye disease treatment videos on Chinese short-video platforms
Purpose: This study aimed to evaluate the quality of dry eye disease (DED) treatment–related short videos on popular Chinese platforms. Methods: To better evaluate the quality of short videos related to DED treatment, the Dry-eye-related Short Videos Standardization Score (DSVSS), a preliminary disease-specific checklist, was developed tailored to DED clinical guidelines. On May 17, 2025, 305 videos (150 from Douyin, 155 from Bilibili) were retrieved using the keyword “dry eye treatment”, and their quality and guideline consistency were evaluated with the Global Quality Score (GQS) and the DSVSS checklist. Basic data, including duration, likes, comments, collections, and shares were recorded. Statistical analysis was performed using the Mann–Whitney U test, Kruskal–Wallis H test, and Spearman’s rank correlation to assess group differences and correlations. Results: Videos from Douyin were generally shorter but achieved higher user engagement, while videos from Bilibili were longer with lower interaction (both P P =0.041), and median DSVSS was 3 for both ( P =0.116). Videos performed poorly in DSVSS checklist in definition and classification [0.05 (IQR 0.03–0.07)], emphasizing chronicity [0.07 (0.05–0.10)], and individualized treatment [0.08 (0.03–0.10)], but performed well in avoiding exaggeration [0.84 (0.63–0.91)], absence of advertising [0.78 (0.66–0.88)], and in providing warnings for special populations [0.91 (0.87–0.96)] (P<0.001). Conclusions: This study effectively identified critical deficiencies of current short-videos on DED treatment, underscoring the necessity for more professional, guideline-based content and stricter platform supervision to improve the quality of online health information.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1) , 3808140
Advantages of Hyperbaric Oxygen Treatment for Type 2 Diabetes Mellitus in Mice: Involvement of Leptin
Background: Hyperbaric oxygen treatment (HBOT) is clinically used to improve oxygen supply to hypoperfused tissues under certain conditions. HBOT can decrease the incidence of autoimmune diabetes in nonobese diabetic mice by reducing apoptosis and increasing β ‐cell proliferation. HBOT ameliorates glucose tolerance in Type 2 diabetes (T2D) mellitus patients, but the underlying mechanism needs further investigation. Methods: We used a diet‐induced T2D mouse model and a genetic mouse model (ob/ob mice) to evaluate the effects of HBOT on serum glucose levels in mice. The body weights and blood glucose levels of the mice were measured weekly. An oral glucose tolerance test (OGTT) was performed 12 weeks after the start of the experiment. All the mice were euthanized, and the serum and liver tissues were collected to test the total cholesterol, triglycerides, alanine aminotransferase, aspartate aminotransferase, malondialdehyde, and antioxidant enzymes. Results: Our results demonstrated that HBOT can delay/attenuate the onset of diet‐associated T2D in wild‐type mice. However, HBOT had no significant effects on blood glucose or T2D incidence in ob/ob mice. Furthermore, we found that HBOT improved glucose tolerance and liver steatosis in diet‐induced T2D model mice but not in ob/ob mice. Our results indicated that the effects of HBOT on T2D were dependent at least partly on the presence of leptin. Conclusion: Our study offers a rationale for using serum leptin as a predictor of clinical outcomes of HBOT and elucidates possible reasons why many patients may experience HBOT failure.
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1) , 3808140
Open AccessAdvantages of Hyperbaric Oxygen Treatment for Type 2 Diabetes Mellitus in Mice: Involvement of Leptin
Background: Hyperbaric oxygen treatment (HBOT) is clinically used to improve oxygen supply to hypoperfused tissues under certain conditions. HBOT can decrease the incidence of autoimmune diabetes in nonobese diabetic mice by reducing apoptosis and increasing β ‐cell proliferation. HBOT ameliorates glucose tolerance in Type 2 diabetes (T2D) mellitus patients, but the underlying mechanism needs further investigation. Methods: We used a diet‐induced T2D mouse model and a genetic mouse model (ob/ob mice) to evaluate the effects of HBOT on serum glucose levels in mice. The body weights and blood glucose levels of the mice were measured weekly. An oral glucose tolerance test (OGTT) was performed 12 weeks after the start of the experiment. All the mice were euthanized, and the serum and liver tissues were collected to test the total cholesterol, triglycerides, alanine aminotransferase, aspartate aminotransferase, malondialdehyde, and antioxidant enzymes. Results: Our results demonstrated that HBOT can delay/attenuate the onset of diet‐associated T2D in wild‐type mice. However, HBOT had no significant effects on blood glucose or T2D incidence in ob/ob mice. Furthermore, we found that HBOT improved glucose tolerance and liver steatosis in diet‐induced T2D model mice but not in ob/ob mice. Our results indicated that the effects of HBOT on T2D were dependent at least partly on the presence of leptin. Conclusion: Our study offers a rationale for using serum leptin as a predictor of clinical outcomes of HBOT and elucidates possible reasons why many patients may experience HBOT failure.